TIGIT and acute myeloid leukemia: As for the bone marrow, we achieved the same findings as Zeng et al., that is, the proportion of TIGIT+ cells in total NK cells, CD56bright, and CD56dim NK cell subsets in bone marrow was comparable between newly diagnosed AML patients and healthy individuals [30].